Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 45802-147

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 45802-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Packaging label for Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride extended release tablets, 5 mg/120 mg strength. The label highlights the product as an antihistamine and nasal decongestant for allergy and congestion relief. The package contains 12 tablets, with branding by Perrigo and a comparison to Zyrtec-D active ingredients. It also lists symptoms the product relieves, such as sneezing and nasal congestion. Labeler information is not visible.*

FDA Label Image

Image 02

Drug Facts label for Cetirizine hydrochloride 5 mg and Pseudoephedrine hydrochloride 120 mg extended release tablets by Padagis Israel Pharmaceuticals Ltd. The label includes active ingredients, uses, warnings, directions, other information on storage, and inactive ingredients. Also shown is the distributor Perrigo's logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.